Results showed that artesunate or dihydroartemisinin significantly increased the cell apoptosis proportion under the treatment of the death receptor 5 (DR5)-specific TRAIL variant DHER in two human colon cancer cell lines (HCT116 and DLD-1). Here, TNFRSF10B is linked to malignant colon neoplasm.